Trial Condition(s):
Human Repeated Insult Patch Test (HRIPT) of Azelaic Acid Pre Foam Formulation
15854
Not Available
Not Available
The purpose of this study is to determine the dermal sensitization potential of azelaic acid pre-foam formulation.
- healthy volunteers - male or female subjects - aged 18 - 65 years - ability to understand and fulfill the study requirements
- affected skin in designated test area - pregnancy or lactation - not willing to comply with study requirements
Locations | Status | |
---|---|---|
Locations Robert I. Cooper, MD Fargo, United States, 58104 | Status Completed | Contact Us: E-mail: [email protected] Phone: Not Available |
A Randomized, Double-blind, Vehicle Controlled Phase 1 Dermal Safety Study to Evaluate the Sensitizing Potential of Topically Applied Azelaic Acid Pre-foam Formulation in Healthy Subjects Using a Human Repeated Insult Patch Test Design
Trial Type:
Interventional
Intervention Type:
Drug
Trial Purpose:
Basic Science
Allocation:
Randomized
Blinding:
Double Blind
Assignment:
Parallel Assignment
Trial Arms:
3